Health

Saudi Arabia to host the first-ever International Conjoined Twins Conference on 24-25 November 2024: KSrelief

RIYADH, Saudi Arabia, July 2, 2024 /PRNewswire/ -- The United Nations has announced that24 November 2024 will be 'World Conjoined Twins Day' and will be observed each year, to emphasize the need to address the condition of conjoined twins, advocate for their treatment and care, and promote their ...

2024-07-02 15:46 1968

Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities

New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of theMedTech Trends to Watch 2024 report, the second installment...

2024-07-02 15:00 1932

HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US

WILMINGTON, Del., July 2, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquis...

2024-07-02 10:00 3417

Cicada Innovations calls for systems approach to 'turbocharge' Future Made in Australia act, announces Tech23 cohort

SYDNEY, July 2, 2024 /PRNewswire/ -- Australia's flagship deep tech incubator Cicada Innovations is urging the tech ecosystem to lead in turbocharging the Future Made inAustralia act by shifting from a "silos" to a "systems" approach that aligns national vi...

2024-07-02 08:06 2944

Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2024-07-02 08:00 3565

Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board

PERTH, Australia, July 2, 2024 /PRNewswire/ -- Bridgewest Perth Pharma, global pharmaceutical holding company withNovaCina CDMO division and LumaCina  pharmaceutical supply division, announces the addition of renown Australian executiveJohn Van Der Wielen to Board of Directors. Van Der Wielen will...

2024-07-02 07:00 2092

Lions Celebrate a Successful Year of Service at the 106th Lions International Convention

OAK BROOK, Ill., July 2, 2024 /PRNewswire/ -- Lions International celebrated several milestones during the 106th Lions International Convention inMelbourne, Australia. Nearly 10,000 Lions attended this pinnacle event to reconnect with Lions from around the world, discover innovative ways to grow ...

2024-07-02 07:00 1763

JCI Publishes 8th Edition of International Accreditation Standards for Hospitals and Academic Medical Centers

8th edition strengthens existing standards to advance patient safety and quality improvement OAKBROOK TERRACE, Ill., July 1, 2024 /PRNewswire/ -- Joint Commission International (JCI) has released the 8th edition of its Accreditation Standards for Hospitals and Academic Medical Centers. These evi...

2024-07-01 21:00 2054

HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board

* Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. * Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Company's global scientific leadership in liver disea...

2024-07-01 20:00 2565

Ping An Co-CEO Michael Guo at "Summer Davos": Low Public Awareness of Financial Planning for Senior Care in China is Opportunity for Financial Services Industry

HONG KONG and SHANGHAI, July 1, 2024 /PRNewswire/ -- China's growing senior population is bringing tremendous business opportunities to the financial services industry, says Michael Guo, Co-CEO of Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", ...

2024-07-01 19:19 4650

"Twenty Years of Collaboration Leading to New Success" - The 20th Anniversary Press Conference of Medtec China Successfully Held in Shanghai

SHANGHAI, July 1, 2024 /PRNewswire/ -- On the morning of June 26, 2024, the  20th Anniversary Press Conference of Medtec China was successfully held at the Grand Kempinski Hotel Shanghai. Mr.Jack Wei, General Manager of Informa Markets Beijing announced Medtec's new development strategy to establ...

2024-07-01 16:08 2024

IFPA Celebrates Success of the 7th IFPA Conference 2024

STOCKHOLM, July 1, 2024 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held fromJune 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference has become...

2024-07-01 16:00 1756

National Cancer Society Malaysia and Gene Solutions Forge Partnership to Expand Multi-Cancer Early Detection Awareness and Access

KUALA LUMPUR, Malaysia, July 1, 2024 /PRNewswire/ -- National Cancer Society Malaysia (NCSM) and Gene Solutions are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on expanding awareness and enabling access to multi-cancer early detection (MCED) testing for t...

2024-07-01 12:55 14175

Egg White Rice - an Innovative Food for the Health-Conscious

BANGKOK, July 1, 2024 /PRNewswire/ -- Chula   Faculty of Allied Health Sciences has launched a ready-to-eat flourless rice innovation made from egg whites, branded as"eggyday ".  This product is low in...

2024-07-01 11:56 2181

SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors

SINGAPORE, July 1, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) appl...

2024-07-01 10:56 1992

Transforming Healthcare with AI: YiduTech's Gong Rujing at Summer Davos

DALIAN, China, July 1, 2024 /PRNewswire/ -- "AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New Champions, ...

2024-07-01 10:17 11184

Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA

HONG KONG, June 31, 2024 /PRNewswire/ -- Yidu Tech Inc. ("Yidu Tech" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group", HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 ("FY2024" or the "Reporting Period"). The manage...

2024-07-01 09:05 18192

CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products

The deal leverages CBC's hands-on "investor-operator" approach to accelerate portfolio companies' asset acquisition and strategic international expansion SINGAPORE, July 1, 2024 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated asset management firm headquartered inSingapore,...

2024-07-01 09:03 1802

ANYTIME FITNESS LAUNCHES "REAL LIFE NEVER STOPS. ANYTIME STARTS NOW."

– REMINDING US THAT FITNESS IS NOT A WANT, IT'S A NEED. SINGAPORE, July 1, 2024 /PRNewswire/ -- Global brand Anytime Fitness sends a wake-up call with its latest campaign, 'Real Life Never Stops. Anytime Starts Now.'. The campaign was designed to inspire individuals to prioritize their health, n...

2024-07-01 09:00 1854

Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.

CASTRES, France, June 28, 2024 /PRNewswire/ -- The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly debilitating condition affecting over 70 million pati...

2024-06-28 23:55 3346
1 ... 40414243444546 ... 580

Week's Top Stories